The NHS is approaching its 70th anniversary and has unveiled its plans to reduce its costs to fund innovative technologies. Innovations include:
- Revolutionary new treatment for Hepatitis C is set to save NHS England more than £50 million as well as saving thousands more lives
- New measures to slash up to another £300 million from the nation’s medicines bill
- An expansion of the test-bed programme testing the treatments and care models of tomorrow
Simon Stevens, NHS England Chief Executive said: “The NHS has a proud history of innovation. As our 70th anniversary approaches it is important that we do not just celebrate these often unsung achievements but also unleash the full potential of innovation in treatment and commissioning to ensure we deliver high quality healthcare for future generations.”
Currently six of the 10 most expensive drugs in the UK are biological medicines, those derived or synthesised from biological material such as viruses, and therefore the most complex to develop and the most costly. In the coming years, more biological medicines are set to lose patent exclusivity and more biosimilar medicines are expected to come into the marketplace, which are hoped to bring significant savings to the NHS without compromising on the safety or effectiveness of their biologic counterparts.